Observational studyScientific reports2026
The impact of preimplantation genetic testing on the quality of life of people undergoing assisted reproduction treatment.
Observational study in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Approximately 20% of infertility cases have a genetic origin. Preimplantation genetic testing (PGT) is an early prenatal diagnostic tool to prevent genetic disorders through embryo selection. Given its complexity, PGT requires a multidisciplinary approach, including psychosocial support, as infertility impacts mental health and overall well-being. Patients undergoing PGT often face prior miscarriages or IVF failures, elevating negative emotions and reducing quality of life. To compare affect levels, need for parenthood, and quality of life in IVF patients with and without PGT indications. This observational cross-sectional study included 375 patients divided into ‘PGT’ (n = 73) and ‘non-PGT’ (n = 302) groups. Participants completed the Positive and Negative Affect Schedule (PANAS), Need for Parenthood scale, and Fertility Quality of Life tool (FERTIQOL). Group comparisons were conducted. The groups did not differ in terms of gender, type and cause of infertility, and psychotropic medication use. The PGT group reported higher negative emotions, lower quality of life compared to the non-PGT group. Both groups showed high levels of need for parenthood. Patients indicated for PGT require greater support and monitoring, experiencing a significant emotional impact from the outset of treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.